These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15074899)

  • 21. Patient retention in mobile and fixed-site methadone maintenance treatment.
    Greenfield L; Brady JV; Besteman KJ; De Smet A
    Drug Alcohol Depend; 1996 Oct; 42(2):125-31. PubMed ID: 8889411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of clients of high- and low-dose methadone programs.
    McGlothlin WH; Anglin MD
    Arch Gen Psychiatry; 1981 Sep; 38(9):1055-63. PubMed ID: 7283663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
    J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of blended treatment literacy and psychoeducation on methadone maintenance treatment outcomes in Yunnan, China.
    Zhang B; Cai T; Yan Z; Mburu G; Wang B; Yang L
    Harm Reduct J; 2016 Feb; 13():8. PubMed ID: 26915361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between methadone maintenance treatment and crime: a 17-year longitudinal cohort study of Canadian provincial offenders.
    Russolillo A; Moniruzzaman A; McCandless LC; Patterson M; Somers JM
    Addiction; 2018 Apr; 113(4):656-667. PubMed ID: 28987068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment.
    Bell J; Trinh L; Butler B; Randall D; Rubin G
    Addiction; 2009 Jul; 104(7):1193-200. PubMed ID: 19563562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A preventive ethics approach to methadone maintenance programmes.
    Townshend PL; Sellman JD; Coverdale JH
    N Z Bioeth J; 2001 Oct; 2(3):7-13. PubMed ID: 15587001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland's drug and alcohol services.
    Moran L; Keenan E; Elmusharaf K
    BMC Health Serv Res; 2018 Nov; 18(1):911. PubMed ID: 30497467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-year retention in methadone opioid agonist treatment: A survival analysis of clients by dose, area deprivation, and availability of alcohol and cannabis outlets.
    Amiri S; Hirchak K; Lutz R; McDonell MG; McPherson SM; Roll JM; Amram O
    Drug Alcohol Depend; 2018 Dec; 193():63-68. PubMed ID: 30340146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment retention and evolution of clientele in a low threshold methadone substitution treatment program in Montreal].
    Perreault M; Héroux MC; White ND; Lauzon P; Mercier C; Rousseau M
    Can J Public Health; 2007; 98(1):33-6. PubMed ID: 17278675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies.
    Gauthier G; Eibl JK; Marsh DC
    Drug Alcohol Depend; 2018 Oct; 191():1-5. PubMed ID: 30064001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of treatment retention in a major methadone maintenance treatment program in iran: a survival analysis.
    Pashaei T; Moeeni M; Roshanaei Moghdam B; Heydari H; Turner NE; Razaghi EM
    J Res Health Sci; 2014; 14(4):291-5. PubMed ID: 25503286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment predictors of tenure in methadone maintenance.
    Joe GW; Simpson DD; Hubbard RL
    J Subst Abuse; 1991; 3(1):73-84. PubMed ID: 1821275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.
    Backmund M; Meyer K; Eichenlaub D; Schütz CG
    Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of early dropout in methadone maintenance treatment program in Yunnan province, China.
    Che Y; Assanangkornchai S; McNeil E; Chongsuvivatwong V; Li J; Geater A; You J
    Drug Alcohol Rev; 2010 May; 29(3):263-70. PubMed ID: 20565518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence.
    Strike CJ; Gnam W; Urbanoski K; Fischer B; Marsh DC; Millson M
    Addict Behav; 2005 Jun; 30(5):1025-8. PubMed ID: 15893099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of 6-year retention in methadone maintenance treatment among opioid-dependent patients in Xi'an.
    Wei X; Wang L; Wang X; Li J; Li H; Jia W
    J Addict Med; 2013; 7(5):342-8. PubMed ID: 23896752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone dosage and retention: an examination of the 60 mg/day threshold.
    Brady TM; Salvucci S; Sverdlov LS; Male A; Kyeyune H; Sikali E; DeSale S; Yu P
    J Addict Dis; 2005; 24(3):23-47. PubMed ID: 16186081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2002; (4):CD002207. PubMed ID: 12519569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlates of methadone client retention: a prospective cohort study in Guizhou province, China.
    Liu E; Liang T; Shen L; Zhong H; Wang B; Wu Z; Detels R
    Int J Drug Policy; 2009 Jul; 20(4):304-8. PubMed ID: 18951777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.